7,874 press releases indexed under healthcare.
SAN FRANCISCO, Sept. 17, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business...
RIYADH, KSA, Sept 18, 2026 - (ACN Newswire) - The Life Sciences Innovation Forum (LSIF), the investment platform of the Riyadh Global Medical Biotechnology Summit (RGMBS 2026), brought 23 biotechnology companies from eight countries to Riyadh to pitch to investors, judges, and leaders of the Kingdom's life sciences ecosystem. Companies from eight countries pitched to investors across five scientific heats, with Saudi Arabia the second-largest market represented. Dr Abdulaziz Alrifi, Director Of Partnerships, KAIMRC, stated, "We were proud to welcome leading investment firms that expressed their willingness to invest more than $USD 120 milliond in promising biotech opportunities emerging from LSIF 2026. The journey culminated with the announcement of the LSIF 2026 Grand Winner: Bilix from South Korea." On winning, a representative of Bilix enthused, "Winning LSIF 2026 is a great honor, however the real win is scaling our startup with the Kingdom's research ecosystem" Where RGMBS 2026 set out the scale of Saudi Arabia's biotechnology ambition, LSIF put that ambition in front of the founders and investors who will shape the sector's next decade. The United States led the cohort with eight companies, with Saudi Arabia second at four, followed by South Korea, the United Kingdom, Australia, France, Germany, and Switzerland. Several international companies presented pathways to localization, research, or clinical development in the Kingdom. FIVE HEATS, ONE FRONTIER Companies competed across five heats, each at the leading edge of life sciences innovation. AI and Bio Data. Amprologix of the United Kingdom presented AI-assisted discovery of narrow-spectrum peptide antibiotics targeting drug-resistant pathogens. Pneumatica Bio of Australia combines mechanistic modelling, machine learning, and automated cell experiments to better predict human therapeutic response, while Saudi company LinusBio MENA presented precision exposomics built on hair-based biomarker profiling. Vaccine Development and Biomanufacturing. Biotech Innovations Company of Saudi Arabia presented a recombinant-protein MERS-CoV vaccine program focused on regional biosecurity and local manufacturing. OctoCells of France presented an animal-free 3D bioscaffold platform designed to reduce the water, infrastructure, and manufacturing burden of producing biologics and cell therapies, and Cevza Therapeutics of Australia an RNA therapy platform with planned research and development localization in the Kingdom. Cellular Therapy and Gene Editing. CellKure of the United States highlighted Phase 1 results for its multi-antigen T-cell therapy in acute myeloid leukemia. MVRIX of South Korea presented an in vivo CAR-T approach using targeted mRNA delivery, and Saudi company Medixcel a platform to bring cell and gene therapy capabilities, partnerships, and manufacturing into the Kingdom. Bioengineering and Synthetic Biology. NanoZymeX of Switzerland presented a lipid nanoparticle platform to improve enzyme replacement therapy for lysosomal storage diseases, beginning with Pompe disease. AUREXO Therapeutics of the United States presented engineered bacterial vesicles for precision oncology, and Ingenskin Therapeutics of France an autologous skin substitute for chronic wounds, burns, and trauma. Diagnostics and Drug Discovery. SiNON Nano Sciences of the United States presented a carbon nanoparticle platform designed to cross the blood-brain barrier. Spirea of the United Kingdom presented a dual-payload antibody-drug conjugate platform to address cancer drug resistance, and Accanito Therapeutics of the United States a clinical-stage oncology platform with a proposal for technology transfer and local manufacturing in Saudi Arabia. Questions from judges and the audience concentrated on turning science into treatments: regulatory routes, clinical evidence, manufacturing scale-up, localization economics, and intellectual property. LSIF 2026 was sponsored by Chiyoda Corporation. Alongside Grand Winner Bilix, four category awards were presented: the Most Scalable Biotech Startup Award to CellKure, the Outstanding Founding Team Award to Quantabia, the Breakthrough Science Award to Swaza, and the Innovation Excellence Award to Agemica. LSIF 2026 took place as part of RGMBS 2026, held from 14 to 16 September in Riyadh. The Summit was organized and supervised by the Ministry of National Guard, represented by its Health Affairs sector, and hosted by King Abdullah International Medical Research Center (KAIMRC) and King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), with the Ministry of Investment, Invest Saudi, and the Saudi Data & AI Authority (SDAIA) serving as key strategic partners. About The Riyadh Global Medical Biotechnology Summit The Riyadh Global Medical Biotechnology Summit is the Kingdom of Saudi Arabia's flagship platform for medical biotechnology, convening the global scientific, investment, and policy communities in Riyadh. Organized and supervised by the Ministry of National Guard, represented by its Health Affairs sector, and hosted by KAIMRC and KSAU-HS, the Summit advances the goals of the National Biotechnology Strategy and supports the Kingdom's emergence as a global destination for health innovation. The fourth edition took place from 14 to 16 September 2026 in Riyadh. rgmbs.org FOR FURTHER INFORMATION Email: PR@legends.sa Telephone: +966 559 810 777 Copyright 2026 ACN Newswire. All rights reserved. www.acnnewswire.com
(PR-inside.com) NEW YORK CITY, NY AND NEW ORLEANS, LA / ACCESS Newswire / September 17, 2026 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until November 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE:HIMS), if they purchased or otherwise acquired the Company's securities between August 4, 2025 and July 29, 2026, inclusive (the "Class Period"). This action is pending in the United States District Court for ..
PONTE VEDRA, Fla., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and other foot & ankle conditions, today announced the presentation of the results from three clinical studies at the American Orthopaedic Foot & Ankle Society (“AOFAS”) Annual Meeting in Seattle, Washington. The presentations include data on the milestone 5-year ALIGN3D ® Lapiplasty ® , the MTA3D ® Adductoplasty ® and the SPRINT™ SpeedPlate ® clinical studies.
Contact: Consumers ICU Medical, Inc. 1-844-654-7780 AUSTIN, Texas, Sept. 17, 2026 /PRNewswire/ -- Otsuka ICU Medical LLC is issuing a voluntary recall for one lot of 0.9% SODIUM CHLORIDE Injection, USP, 100 mL single pack to the user level due to a potential mix-up. The affected lot of...
HOLLYWOOD, Fla., Sept. 17, 2026 /PRNewswire/ -- Joe DiMaggio Children's Hospital at Memorial Healthcare System has once again been named one of U.S. News & World Report's 2026-2027 Best Children's Hospitals, earning top rankings in five pediatric specialties. "This recognition belongs to...
New York, New York--(Newsfile Corp. - September 17, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026 (the "Class Period").CLICK HERE TO JOIN THE CASEIf you are an investor in Hims & Hers and have suffered losses, you may CLICK HERE to contact us. You may...
LEWISVILLE, Texas, September 17, 2026--GMR Solutions Inc. ("GMR") (NYSE: GMRS), the nation’s largest provider of emergency medical services, completed successful repricing of all its existing $2.9 billion Term Loan B facility due October 2032.
BOSTON, September 17, 2026--US Family Health Plan of Southern New England (USFHP), a Department of Defense-sponsored TRICARE Prime health plan administered by BrightonOne, today announced a major expansion of its Connecticut network, giving eligible military families and retirees access to nearly 9,000 additional medical professionals across the state. The expanded network, which includes Yale New Haven Health and Trinity Health of New England in a health plan created for the military community,
(PR-inside.com) VANCOUVER, BC / ACCESS Newswire / September 17, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences and longevity company focused on preventative wellness and healthspan extension, and parent of the Vanta premium longevity brand, announces that representatives of the Company attended the 2026 All-In Summit (the "All-In Summit"), held September 13-15, 2026, in Los Angeles, California. Over the course of the three-day summit, Vanta representatives engaged with founders, investors, executives, entrepreneurs and industry participants across sectors aligned with the Company's broader growth strategy, including healthcare, biotechnology and technology. These discussions provided opportunities to establish ..
CAMBRIDGE, Mass., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the publication of results from a prespecified adolescent subgroup analysis of the Phase 3 VALIANT study evaluating EMPAVELI® (pegcetacoplan) in the Clinical Journal of the American Society of Nephrology (CJASN). The dedicated subgroup analysis was first presented at the 2025 Annual Meeting of the European Society of Paediatric Nephrology (ESPN).
The philanthropies will support school meals in Ghana's Eastern Region and Kenya's Bomet County to improve nutrition, learning, attendance, and help keep children out of child labor. School meals have been proven to reduce child poverty and exploitation, food insecurity, and poor health...